questionText: To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that people with cystic fibrosis have access to Orkambi, Symkevi and Kaftrio on the NHS.
answerText: In July 2024, National Institute for Health and Care Excellence (NICE) approved three disease modifying treatments, Orkambi, Symkevi, and Kaftrio, as treatment options for eligible National Health Service patients with cystic fibrosis, under the terms of ...
heading: Cystic Fibrosis: Drugs